Thus, the protection of the intestinal barrier integrity exerted by GLP-2 and by substances that counteract dysbiosis could represent an interesting strategy to attenuate inflammation in obesity and its associated comorbidities. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.